CIRIXCOV
Live / Registered — Registered (as of 30 Jan 2024)
What this means for you
Registered since 30 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97315536
- Registration number
- 7292767
- Mark type
- Stylized text
- Filed
- 16 Mar 2022
- Published for opposition
- 14 Nov 2023
- Registered
- 30 Jan 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 30 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Nov 2023 — PUBLISHED FOR OPPOSITION
- 25 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Oct 2023 — NOTICE OF ALLOWANCE CANCELLED
- 03 Oct 2023 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 03 Oct 2023 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 02 Oct 2023 — ASSIGNED TO PETITION STAFF
- 18 Sept 2023 — TEAS PETITION TO AMEND BASIS RECEIVED
- 22 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2023 — SOU EXTENSION 1 GRANTED
- 18 Aug 2023 — SOU EXTENSION 1 FILED
- 18 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT